Santulli G, Varzideh F, Qin Y, Wang B, Kansakar U, Jankauskas S
J Mol Cell Cardiol Plus. 2025; 10():100092.
PMID: 39801807
PMC: 11708110.
DOI: 10.1016/j.jmccpl.2024.100092.
Su R, Wen Z, Zhan X, Long Y, Wang X, Li C
Cell Death Dis. 2024; 15(8):615.
PMID: 39179585
PMC: 11343752.
DOI: 10.1038/s41419-024-07006-9.
Ochs-Balcom H, Preus L, Du Z, Elston R, Teerlink C, Jia G
Hum Mol Genet. 2024; 33(8):687-697.
PMID: 38263910
PMC: 11000665.
DOI: 10.1093/hmg/ddae002.
Higashi T, Saigo C, Chikaishi W, Hayashi H, Hanamatsu Y, Futamura M
Thorac Cancer. 2024; 15(7):513-518.
PMID: 38258402
PMC: 10912533.
DOI: 10.1111/1759-7714.15189.
Pohl G, Goz M, Gaertner A, Brodehl A, Cimen T, Saguner A
Front Cardiovasc Med. 2023; 10:1127261.
PMID: 37273868
PMC: 10235514.
DOI: 10.3389/fcvm.2023.1127261.
Potential activity of adiponectin-expressing regulatory T cells against triple-negative breast cancer cells through the cell-in-cell phenomenon.
Chikaishi W, Higashi T, Hayashi H, Hanamatsu Y, Kito Y, Futamura M
Thorac Cancer. 2023; 14(20):1941-1945.
PMID: 37220892
PMC: 10344742.
DOI: 10.1111/1759-7714.14940.
CDH13 is a prognostic biomarker and a potential therapeutic target for patients with clear cell renal cell carcinoma.
Shao Y, Li W, Zhang L, Xue B, Chen Y, Zhang Z
Am J Cancer Res. 2022; 12(10):4520-4544.
PMID: 36381315
PMC: 9641392.
Endothelial cells of pulmonary origin display unique sensitivity to the bacterial endotoxin lipopolysaccharide.
Morsing S, Zeeuw van der Laan E, van Stalborch A, van Buul J, Vlaar A, Kapur R
Physiol Rep. 2022; 10(8):e15271.
PMID: 35439361
PMC: 9017980.
DOI: 10.14814/phy2.15271.
Evaluating Anticancer and Immunomodulatory Effects of (Arthrospira) and Gamma-Tocotrienol Supplementation in a Syngeneic Mouse Model of Breast Cancer.
Subramaiam H, Chu W, Radhakrishnan A, Chakravarthi S, Selvaduray K, Kok Y
Nutrients. 2021; 13(7).
PMID: 34371830
PMC: 8308567.
DOI: 10.3390/nu13072320.
Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W, Zhang S, Guo H, Chen X, Huang Z, Jiang S
Cell Commun Signal. 2021; 19(1):39.
PMID: 33761933
PMC: 7992844.
DOI: 10.1186/s12964-021-00728-9.
Genotypes and Haplotypes in the Cholesterol-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival.
Deng W, Liu H, Luo S, Clarke J, Glass C, Su L
Cancer Epidemiol Biomarkers Prev. 2020; 29(6):1204-1213.
PMID: 32238407
PMC: 7269811.
DOI: 10.1158/1055-9965.EPI-19-1262.
Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling.
Xu D, Yuan H, Meng Z, Yang C, Li Z, Li M
J Cancer. 2020; 11(8):2101-2112.
PMID: 32127937
PMC: 7052920.
DOI: 10.7150/jca.37762.
promoter methylation in peripheral blood cells and predisposition to breast cancer.
Al-Moghrabi N
J Taibah Univ Med Sci. 2019; 12(3):189-193.
PMID: 31435238
PMC: 6695050.
DOI: 10.1016/j.jtumed.2017.01.004.
Effect of T-cadherin on the AKT/mTOR signaling pathway, gastric cancer cell cycle, migration and invasion, and its association with patient survival rate.
Lin J, Chen Z, Huang Z, Chen F, Ye Z, Lin S
Exp Ther Med. 2019; 17(5):3607-3613.
PMID: 30988743
PMC: 6447793.
DOI: 10.3892/etm.2019.7350.
Genetic variation in gene was associated with non-small cell lung cancer (NSCLC): A population-based case-control study.
Li Y, Li C, Ma Q, Zhang Y, Yao Y, Liu S
Oncotarget. 2018; 9(1):881-891.
PMID: 29416663
PMC: 5787520.
DOI: 10.18632/oncotarget.22971.
Upregulation of T-cadherin suppresses cell proliferation, migration and invasion of gastric cancer .
Lin J, Chen Z, Huang Z, Chen F, Ye Z, Lin S
Exp Ther Med. 2017; 14(5):4194-4200.
PMID: 29104635
PMC: 5658734.
DOI: 10.3892/etm.2017.5090.
T-cadherin is associated with prognosis in triple-negative breast cancer.
Kong D, Wang M, Yang J, Li L, Wang W, Wang S
Oncol Lett. 2017; 14(3):2975-2981.
PMID: 28928835
PMC: 5588130.
DOI: 10.3892/ol.2017.6505.
Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines.
Ye M, Huang T, Li J, Zhou C, Yang P, Ni C
Medicine (Baltimore). 2017; 96(4):e5956.
PMID: 28121942
PMC: 5287966.
DOI: 10.1097/MD.0000000000005956.
HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability.
Zhao J, Fang F, Guo Y, Zhu T, Yu Y, Kong F
J Exp Clin Cancer Res. 2016; 35(1):180.
PMID: 27884161
PMC: 5123399.
DOI: 10.1186/s13046-016-0454-4.
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis.
Chen F, Huang T, Ren Y, Wei J, Lou Z, Wang X
BMC Urol. 2016; 16(1):52.
PMID: 27578166
PMC: 5004266.
DOI: 10.1186/s12894-016-0171-5.